Comparing two ways to give CDR132L in healthy volunteers
Treatments studied
Part of Heart & circulation clinical trials.
This study measures how well the drug CDR132L enters the blood when injected under the skin, compared to injection into a vein. It is done in healthy volunteers to find the best way to give the drug.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 55 years old.
- Your body mass index (BMI) is between 18.5 and 29.9, and you weigh less than 120 kilograms (about 265 pounds).
- You are generally healthy, with no major heart, kidney, blood, or brain conditions.
- You have normal blood pressure, heart rate, and heart rhythm (confirmed by screening tests).
- Your blood and urine lab results are within a normal range (checked during screening).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if CDR132L can improve heart structure and function in people with a type of heart failure where the heart pumps normally but is stiff and thickened. It may help if you have heart failure with preserved ejection fraction and a thickened heart muscle.
This trial tests a new medicine called CDR132L to see if it improves heart structure and function in people with heart failure who have a thickened heart muscle and reduced pumping ability. Participants will be randomly assigned to receive either the study drug or a placebo.
This trial tests how a drug (BMS-986435) behaves in people with normal liver function versus those with liver problems. It also checks that the drug is safe for the heart.
This study tests a new drug to see how it is absorbed, distributed, and removed from the body. It is given as a shot to healthy men, and the results will help determine the right dose for future studies.
This study tests different forms of an experimental medicine called HRS-5346 to see how the body absorbs them. It is for healthy people aged 18 to 45, and the results will help decide which version to use in future studies.
This study tests a new medicine (INCA033989) given as a shot or IV in healthy adults to see how the body processes it and if it's safe.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.